Protect Animal Health (寶泰生醫) multicenter field trial

Research organization

1 current cancer treatment or research opportunity

About the Protect Animal Health field trial

Protect Animal Health is a Taiwanese biotechnology company developing immune treatments for dogs with cancer. It coordinates a network of veterinary hospitals so a new treatment can be tested in patients under everyday clinical conditions.

Official PT001 recruitment notice →

Who the current listings are forDogs
Cancer types currently listedOral Melanoma

Current options at Protect Animal Health (寶泰生醫) multicenter field trial

Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.

PT001 PD-L1/CTLA-4 recombinant protein therapeutic vaccine for stage II-III canine oral malignant melanoma

Protect Animal Health (寶泰生醫) multicenter field trial · Taiwan

Recruiting — multicenter field trial

What is being offered: Official sponsor recruitment notice dated 2025-10-26 remains publicly listed; sponsor subsequently announced regulatory approval to conduct the Taiwan field trial on 2025-11-03 and continues to describe PT001 as an active oncology development program in 2026. Multicenter randomized open-label two-arm field trial of PT001, a PD-L1 and CTLA-4 recombinant-protein therapeutic vaccine, for confirmed stage II-III canine oral malignant melanoma. Age >=1 year. Owners must agree to suspend other cancer treatment. Excludes severe liver/kidney disease, autoimmune disease, bone-marrow disease or other high-risk systemic disease, dogs requiring steroids/immunosuppressants, and prior radiation. Tumor must be recordable/measurable. Trial contains a control arm. Final screening by study site is required.

Who may qualify: Confirmed cancer diagnosis required; Min age years: 1; Measurable; Oral melanoma stage ii or iii; Other treatments suspended

May not qualify if: Prior local radiation; Current steroids; Immunosuppressive

Costs / coverage: The current protocol page does not state which treatment, testing or follow-up costs are covered; confirm directly with the study team.

Contact: Participating veterinary hospitals listed on the official recruitment page; screening through the study sites.

Participating locations

  • National Taiwan University Veterinary Hospital, No. 153, Sec. 3, Keelung Rd, Da'an Dist, Taipei City 10672, Taiwan
  • Evergreen Animal Hospital, No. 78 Guangzhou St, Wanhua Dist, Taipei City, Taiwan
  • Duma Animal Hospital, No. 136 Zhongyuan St, Zhonghe Dist, New Taipei City, Taiwan
  • National Chung Hsing University Veterinary Teaching Hospital, No. 21, Sec. 1, Xiangshang Rd, West Dist, Taichung City, Taiwan
  • Bubble Animal Hospital, No. 102, Sec. 1, Longde Rd, Nantun Dist, Taichung City, Taiwan
  • Jimmy Harry Animal Hospital, No. 250 Dasheng St, Nantun Dist, Taichung City 408, Taiwan
  • Woke Animal Hospital, No. 776, Sec. 4, Wenxin Rd, Beitun Dist, Taichung City, Taiwan

Official study / enrollment information →

Before you contact the center

A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.

Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.

Check all options for your pet →

Free to use. No registration or paid report.